NS Healthcare is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

Continue Learn More X

FDA advisory committee recommends Pfizer Covid-19 vaccine for kids five to 11 years

By NS Healthcare Staff Writer 27 Oct 2021

The FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) reviewed the data, and voted 17 to 0, with one abstention

Gilead, Merck begin Phase 2 study of investigational....

The regimen includes Merck’s nucleoside reverse transcriptase translocation inhibitor islatravir and Gilead’s

Novartis’ cancer drug canakinumab fails in Phase 3....

The Phase 3 CANOPY-1 study did not meet its primary endpoints of

Moderna’s Covid-19 vaccine found effective in kids aged....

In the Phase 2/3 study, two 50μg doses of mRNA-1273 were generally

Genentech gets US FDA nod for Susvimo to....

Susvimo, earlier known as Port Delivery System with ranibizumab, is said to

Pharmaceuticals

BMS gets EC approval for Opdivo combination to treat gastrointestinal cancers
22 Oct 21

Novartis to support manufacture of Pfizer-BioNTech Covid-19 vaccine
22 Oct 21

US FDA authorises Moderna, J&J Covid-19 booster shots for emergency use
21 Oct 21

Patient Care

Click Therapeutics secures $52m in Series B financing
25 Oct 21

FDA advisory committee recommends Pfizer Covid-19 vaccine for kids five to 11 years

Gilead, Merck begin Phase 2 study of investigational....

Novartis’ cancer drug canakinumab fails in Phase 3....

Moderna’s Covid-19 vaccine found effective in kids aged....

Genentech gets US FDA nod for Susvimo to....

Pharmaceuticals

BMS gets EC approval for Opdivo combination to treat gastrointestinal cancers
22 Oct 21

Novartis to support manufacture of Pfizer-BioNTech Covid-19 vaccine
22 Oct 21

US FDA authorises Moderna, J&J Covid-19 booster shots for emergency use
21 Oct 21

Patient Care

Click Therapeutics secures $52m in Series B financing
25 Oct 21

LumiraDx SARS-CoV-2 Antigen test granted emergency use approval in India
21 Oct 21

WHO recommends use of GSK’s malaria vaccine for children at risk
08 Oct 21

Nutraceuticals

Hope on the horizon for lactose intolerance
14 Oct 21

Challenging perceptions: the rise of CBD
07 Oct 21

Catalent agrees to acquire gummies manufacturer Bettera for $1bn
31 Aug 21

NS Healthcare is using cookies

BMS gets EC approval for Opdivo combination to treat gastrointestinal cancers22 Oct 21

Novartis to support manufacture of Pfizer-BioNTech Covid-19 vaccine22 Oct 21

US FDA authorises Moderna, J&J Covid-19 booster shots for emergency use21 Oct 21

Click Therapeutics secures $52m in Series B financing 25 Oct 21

LumiraDx SARS-CoV-2 Antigen test granted emergency use approval in India 21 Oct 21

WHO recommends use of GSK’s malaria vaccine for children at risk 08 Oct 21

Hope on the horizon for lactose intolerance14 Oct 21

Challenging perceptions: the rise of CBD07 Oct 21

Catalent agrees to acquire gummies manufacturer Bettera for $1bn31 Aug 21

OUR TITLES

US FDA approves Roche’s Tecentriq as....18 Oct 21

The psychological toll of Covid-19 on....14 Sep 21

Horizons open for further laboratory automation09 Aug 21

Ro raises $500m funding to expand....24 Mar 21

PCI to acquire lyophilisation services provider....13 Oct 21

Sandoz closes acquisition of GSK’s cephalosporin....11 Oct 21

Boston Scientific to acquire Baylis Medical....07 Oct 21

AstraZeneca to buy remaining stake in....30 Sep 21

Cipla to distribute Lilly’s diabetes drugs....05 Oct 21

Merck, GSK terminate $4.5bn deal on....01 Oct 21

Regeneron to supply additional doses of....15 Sep 21

AstraZeneca reaches settlement with EC over....06 Sep 21

BMS gets EC approval for Opdivo combination to treat gastrointestinal cancers
22 Oct 21

Novartis to support manufacture of Pfizer-BioNTech Covid-19 vaccine
22 Oct 21

US FDA authorises Moderna, J&J Covid-19 booster shots for emergency use
21 Oct 21

Click Therapeutics secures $52m in Series B financing
25 Oct 21

LumiraDx SARS-CoV-2 Antigen test granted emergency use approval in India
21 Oct 21

WHO recommends use of GSK’s malaria vaccine for children at risk
08 Oct 21

Hope on the horizon for lactose intolerance
14 Oct 21

Challenging perceptions: the rise of CBD
07 Oct 21

Catalent agrees to acquire gummies manufacturer Bettera for $1bn
31 Aug 21

US FDA approves Roche’s Tecentriq as....
18 Oct 21

The psychological toll of Covid-19 on....
14 Sep 21

Horizons open for further laboratory automation
09 Aug 21

Ro raises $500m funding to expand....
24 Mar 21

PCI to acquire lyophilisation services provider....
13 Oct 21

Sandoz closes acquisition of GSK’s cephalosporin....
11 Oct 21

Boston Scientific to acquire Baylis Medical....
07 Oct 21

AstraZeneca to buy remaining stake in....
30 Sep 21

Cipla to distribute Lilly’s diabetes drugs....
05 Oct 21

Merck, GSK terminate $4.5bn deal on....
01 Oct 21

Regeneron to supply additional doses of....
15 Sep 21

AstraZeneca reaches settlement with EC over....
06 Sep 21